LAVA Therapeutics Stock Forecast

Stock Price Forecast

The 3 analysts with 12-month price forecasts for LAVA Therapeutics stock have an average target of 3.17, with a low estimate of 1.50 and a high estimate of 6.00. The average target predicts an increase of 147.87% from the current stock price of 1.28.

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$1.50	$3.17	$2.00	$6.00
Change	+17.29%	+147.87%	+56.38%	+369.15%

* Price targets were last updated on Mar 31, 2025.

Analyst Ratings

The average analyst rating for LAVA Therapeutics stock from 3 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Dec '24	Jan '25	Feb '25	Mar '25	Apr '25	May '25
Strong Buy	1	1	0	0	0	0
Buy	0	0	0	0	0	0
Hold	2	2	3	3	3	3
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	3	3	3	3	3	3

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Arthur He HC Wainwright & Co.	HC Wainwright & Co.	Hold Reiterates $1.5	Hold	Reiterates	$1.5	+17.29%	Mar 31, 2025
Arthur He HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy → Hold Downgrades $2 → $1.5	Strong Buy → Hold	Downgrades	$2 → $1.5	+17.29%	Feb 27, 2025
Arthur He HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $6 → $2	Strong Buy	Maintains	$6 → $2	+56.38%	Dec 20, 2024
Daina Graybosch Leerink Partners	Leerink Partners	Buy → Hold Downgrades $11 → $2	Buy → Hold	Downgrades	$11 → $2	+56.38%	Dec 12, 2024
Reni Benjamin JMP Securities	JMP Securities	Buy → Hold Downgrades $6	Buy → Hold	Downgrades	$6	+369.15%	Dec 11, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

from 11.98M

Revenue Next Year

n/a

EPS This Year

-1.56

from -0.94

EPS Next Year

-0.93

from -1.56

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	3.75M	5.35M	19.39M	6.77M	11.98M	-	-	-
Revenue Growth	-	42.78%	262.45%	-65.09%	77.01%	-	-	-
EPS	-39.90	-2.14	-1.23	-1.57	-0.94	-1.56	-0.93	-0.41
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	6	6	5

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	n/a	n/a	n/a
Avg	n/a	n/a	n/a
Low	n/a	n/a	n/a

Revenue Growth

Revenue Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

EPS Forecast

EPS	2025	2026	2027
High	-1.41	-0.49	-0.35
Avg	-1.56	-0.93	-0.41
Low	-1.64	-1.75	-0.47

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.